Markets:

Overview

News

Currencies

International

Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

27.18 +0.94 (+3.58%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Beta Bionics, Inc. - Common Stock

The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep? ↗

November 10, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

October 29, 2025

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Beta Bionics (BBNX) Q3 2025 Earnings Transcript ↗

October 29, 2025

Beta Bionics (BBNX) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings Supply Chain

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock ↗

July 30, 2025

Via Benzinga

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

October 28, 2025

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Beta Bionics Inc (NASDAQ:BBNX) Tops Q3 2025 Revenue Estimates and Raises Full-Year Guidance ↗

October 28, 2025

Beta Bionics (BBNX) beat Q3 2025 revenue estimates and raised its full-year guidance. The medical device company reported strong user growth and a narrower-than-expected loss.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 28, 2025

Via Benzinga

Demystifying Beta Bionics: Insights From 5 Analyst Reviews ↗

October 21, 2025

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Beta Bionics ↗

October 01, 2025

Via Benzinga

Beta Bionics (BBNX) Q2 Revenue Soars 54% ↗

July 30, 2025

Via The Motley Fool

Topics Intellectual Property

Beta Bionics BBNX Q2 2025 Earnings Call Transcript ↗

July 30, 2025

Via The Motley Fool

Topics Earnings

Beta Bionics Inc (NASDAQ:BBNX) Surpasses Q2 2025 Estimates and Raises Full-Year Guidance ↗

July 29, 2025

Beta Bionics (BBNX) beats Q2 2025 revenue and EPS estimates, raises full-year guidance. Shares surge 5.7% as iLet Bionic Pancreas and new insulin pump drive growth.

Via Chartmill

Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns ↗

July 03, 2025

Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 03, 2025

Via Benzinga

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges ↗

June 02, 2025

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.

Via Benzinga

Beta Bionics Stock Gains After Mixed Analyst Coverage; Wolfe Bullish, Goldman Neutral ↗

May 30, 2025

Wolfe Research initiated coverage with an ‘Outperform’ rating and a $20 target, while Goldman Sachs started at ‘Neutral’ with a $16 target, citing balanced growth prospects and valuation.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 07, 2025

Via Benzinga

Earnings Scheduled For March 25, 2025 ↗

March 25, 2025

Via Benzinga

This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

February 24, 2025

Via Benzinga

This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

February 20, 2025

Via Benzinga

Infinity Natural Resources Valued At $1.3 Billion In Market Debut ↗

February 02, 2025

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3 billion. The listing arrived amid a more fossil fuel-friendly White House...

Via Talk Markets

Topics Energy Stocks / Equities

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

Headline News about Beta Bionics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today